Lanx Announces Improved Patient Outcomes Data and Reduced Hospital Costs With ASPEN™ MIS Fusion System

BROOMFIELD, Colo., Oct. 11, 2012 (GLOBE NEWSWIRE) -- Lanx, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced that new clinical data shows that lumbar fusion with the ASPEN™ MIS Fusion System may lead to improved patient outcomes and reduced hospital costs when compared to lumbar fusion with pedicle screws. Three posters on the research were presented at the 2012 Congress of Neurological Surgeons Annual Meeting, Oct. 6-10 in Chicago, Illinois.

MORE ON THIS TOPIC